<DOC>
	<DOCNO>NCT00499824</DOCNO>
	<brief_summary>To test whether International Diabetes Federation - Western Pacific Region ( IDF-WPR ) Guidelines effective standard practice primary care ( general practitioner ) clinic management type 2 diabetes mellitus ( T2DM ) Asia . A 12-month multinational multicentre prospective cluster randomisation clinical trial within primary care setting , 2 parallel treatment arm : diabetes management use IDF-WPR guideline versus standard clinic practice . 400 subject recruit 100 site ( 4 subject per site ) ten Asian country ( China , Hong Kong , Indonesia , Korea , Malaysia , Philippines , Singapore , Taiwan , Thailand Vietnam ) .</brief_summary>
	<brief_title>GIANT : General Practitioner Implementation Asia Normoglycaemic Targets</brief_title>
	<detailed_description>Description intervention ( ) / exposure control treatment : This prospective multinational , multicentre , cluster-randomised study conduct within primary care set , two parallel treatment arm : standard clinical practice versus education diabetes management use International Diabetes Federation - Western Pacific Region ( IDF-WPR ) `` Type 2 diabetes practical target treatment '' . The study duration 12 month . 100 General Practitioners ( GPs ) ( 10 per country ) randomise receive education IDF-WPR guideline receive trial-related education . - GPs group require recruit 4 patient meet eligibility criterion . The complete entry criterion detail follow section . - GPs group manage recruit patient accord clinical judgement . Frequency patient visit GP 's clinic determine GP . All medication prescribe GPs already register participate country . - Blood sample patient require Study Visit 1 ( Screening/Baseline ) , Study Visit 2 ( month 6 ) Study Visit 3 ( month 12 ) . The intervention comprise educational program guideline GPs , carry national coordinating centre country , base template provide international coordinating centre ( International Diabetes Institute , Australia ) . The educational program GPs randomise intervention arm : 1 . Combine didactic interactive session . 2 . Involve opinion leader , i.e . national lead investigator 3 . Aim resolve barrier practical implementation guideline already identify previous study ( e.g . discuss start insulin ) 4 . Present evidence guideline . 5 . Highlight conflict guideline local prescribe regulation , confirm need follow local prescribing regulation instance 6 . Involve initial educational symposium follow-up continue medical education symposium 3 month Organisational change improve guideline adherence study include : 1 . Paper electronic reminder guideline send GPs every 3 month . 2 . Desktop reminder card key guideline algorithm . 3 . Insertion flowsheet ( diabetes action plan ) patient 's medical note study nurse ( time review practitioner 's baseline HbA1c utilisation ) . Patient-centred approach improve guideline adherence study include : 1 . Encouragement empowerment patient ask question treat practitioner 2 . Provision patient `` diabetes passport '' hold patient , encourage discussion patient practitioner also record result medical examination . This provided baseline visit national coordinating centre .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>INCLUSION CRITERIA Men woman 30 75 year age ( inclusive ) Study Visit 1 . Clinical diagnosis type 2 diabetes ( define accord IDF Guidelines ) minimum 6 month prior Study Visit 1 Patients GP primary medical provider diabetes care referral another doctor diabetes care anticipate within 3 month Study Visit 1 Patients give inform consent participate . EXCLUSION CRITERIA Patients type 1 diabetes mellitus Patients previous episode ketoacidosis Patients require chronic use ( &gt; /= 6 month ) insulin time past , exception female pregnancy Patients receive insulin treatment Study Visit 1 within previous 6 month , exception patient receive shortterm treatment ( = 7 day ) insulin maintain glycaemic control acute event ( e.g . hospitalisation medical procedure/intervention , infection trauma ) . Treatment glucocorticoid Study Visit 1 within previous 6 month , exception topical inhale glucocorticoid Females pregnant consider pregnancy stop contraception within course study Patients endstage renal disease , define glomerular filtration rate ( GFR ) MDRD ( Modification Diet Renal Disease ) formula &lt; 15 ml/min/1.73 m2 , renal replacement therapy haemodialysis , peritoneal dialysis renal transplant . Patients psychiatric disease , active drug alcohol abuse cognitive impairment may interfere treatment compliance . Receipt investigational drug within 30 day Study Visit 1 . Patients receive diabetes care another doctor ( specialist endocrinologist , general physician , another GP ) Other eligibility criterion considerations The HbA1c entry newly recruit patient monitor centrally . If significant risk 25 % total study population baseline HbA1c &lt; /= 6.5 % , recruitment subsequent patient restrict HbA1c &gt; 6.5 % .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>Management guideline</keyword>
	<keyword>Efficacy</keyword>
</DOC>